A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 19
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ST
Long Form : scaffold thrombosis
No. Year Title Co-occurring Abbreviation
2021 Optimal Dual Antiplatelet Therapy Duration for Bioresorbable Scaffolds: an Individual Patient Data Pooled Analysis of the ABSORB Trials. aHR, BRS, DAPT, MI
2021 Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium. BVS, TLF, TLR, TV-MI
2018 Clinical outcomes of bioresorbable vascular scaffold to treat all-comer patients. Are patients with acute coronary syndrome better candidates for bioresorbable vascular scaffold? ACS, BVS, DOCE, TLR, TV-MI
2018 Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial. BVS, CoCr-EES, TLF
2018 Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data. MI, PCI, TLR, TVR
2017 Evaluation of bioresorbable vascular scaffolds in acute coronary syndrome: A two-center, one-year follow-up analysis. ACS, BVS, MI, NSTEMI, STEMI, TLR, TVF, TVR, UA
2017 Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study. BRS, Ca, Ca, non-Ca
2017 Two-year clinical outcomes of patients treated with overlapping absorb scaffolds: An analysis of the ABSORB EXTEND single-arm study. MACE, MI, OVP, TLR
2017 Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review andaMeta-Analysis. BVS, CI, EES, OR, TLF, VLST
10  2016 Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis. BRS, DAPT, MACE, TAT, TLR, TVF
11  2016 Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry. BVS
12  2016 Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivity. ADP, BVS, PCI, TSA
13  2016 Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study. BVS, EES, STEMI
14  2016 Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry. BVS, CTO
15  2016 Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation. BRS, MB, MI, SB, TLR, TVR
16  2016 Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis. ACS, BVS, CIs, DES, MI, OR, ORs, PCI
17  2015 Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? BVS
18  2015 Bioresorbable vascular scaffold thrombosis in an all-comer patient population: single-center experience. ACS, BVSs
19  2014 Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. BVS